Kong L - Search Results

1

The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y. Kong L, et al. Cancer. 2006 Sep 15;107(6):1287-93. doi: 10.1002/cncr.22119. Cancer. 2006. PMID: 16909425 Free article.

2

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.

Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM. Lu JJ, et al. Among authors: kong l. Oral Oncol. 2008 Jul;44(7):703-9. doi: 10.1016/j.oraloncology.2007.09.005. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061528 Clinical Trial.

3

The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.

Pan J, Kong L, Lin S, Chen G, Chen Q, Lu JJ. Pan J, et al. Among authors: kong l. Laryngoscope. 2008 Nov;118(11):1970-5. doi: 10.1097/MLG.0b013e3181805134. Laryngoscope. 2008. PMID: 18758376

4

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.

Kong L, Zhang YW, Hu CS, Guo Y. Kong L, et al. Chin J Cancer. 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. Chin J Cancer. 2010. PMID: 20426907 Free article. Clinical Trial.

5

Radiation-induced cranial nerve palsy: a cross-sectional study of nasopharyngeal cancer patients after definitive radiotherapy.

Kong L, Lu JJ, Liss AL, Hu C, Guo X, Wu Y, Zhang Y. Kong L, et al. Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1421-7. doi: 10.1016/j.ijrobp.2010.01.002. Epub 2010 Jun 3. Int J Radiat Oncol Biol Phys. 2011. PMID: 20605344

6

Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.

Ou X, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C. Ou X, et al. Among authors: kong l. Oral Oncol. 2012 Oct;48(10):1045-1050. doi: 10.1016/j.oraloncology.2012.04.011. Epub 2012 May 24. Oral Oncol. 2012. PMID: 22633108

7

Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Niu X, Hu C, Kong L. Niu X, et al. Among authors: kong l. J Cancer Res Clin Oncol. 2013 Jun;139(6):1063-71. doi: 10.1007/s00432-013-1419-z. Epub 2013 Mar 24. J Cancer Res Clin Oncol. 2013. PMID: 23525586

8

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.

Kong L, Hu C, Niu X, Zhang Y, Guo Y, Tham IW, Lu JJ. Kong L, et al. Cancer. 2013 Dec 1;119(23):4111-8. doi: 10.1002/cncr.28324. Epub 2013 Aug 27. Cancer. 2013. PMID: 24037893 Free article. Clinical Trial.

9

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.

Niu X, Chang X, Gao Y, Hu C, Kong L. Niu X, et al. Among authors: kong l. Radiat Oncol. 2013 Oct 2;8:226. doi: 10.1186/1748-717X-8-226. Radiat Oncol. 2013. PMID: 24083351 Free PMC article.

10

Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.

Shi Q, Shen C, Kong L, Wang X, Ding J, Gao Y, Xu T, Hu C. Shi Q, et al. Among authors: kong l. Radiat Oncol. 2014 Jan 6;9:7. doi: 10.1186/1748-717X-9-7. Radiat Oncol. 2014. PMID: 24393418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,310 results

Search Page

Filters